{"id":57141,"date":"2024-02-27T17:25:48","date_gmt":"2024-02-27T17:25:48","guid":{"rendered":"https:\/\/medsname.com\/lasix\/"},"modified":"2026-05-01T10:49:13","modified_gmt":"2026-05-01T10:49:13","slug":"lasix","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/lasix\/","title":{"rendered":"Lasix"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 R\u0103spuns rapid \u2014 Ce este Lasix?<\/h3>\n<p style=\"margin:0;\"><strong>Lasix<\/strong> este un <strong>comprimat de furosemid\u0103 40 mg<\/strong> de la Sanofi \u2014 un <strong>diuretic de ans\u0103 (derivat sulfonamidic)<\/strong> care ac\u021bioneaz\u0103 asupra <strong>NKCC2 (cotransportor Na-K-2Cl) \u00een ramura ascendent\u0103 groas\u0103 a ans\u0103i Henle<\/strong>. Furosemida (frusemid\u0103 \u00een nomenclatura din Marea Britanie\/India) a fost introdus\u0103 de Hoechst \u00een 1964 ca <strong>Lasix<\/strong> \u2014 \u201cDur\u0103 \u0219ase ore\u201d, durata eponim\u0103 a efectului s\u0103u diuretic. Primul diuretic de ans\u0103 \u0219i \u00eenc\u0103 cel mai prescris, cu utilizare extins\u0103 at\u00e2t \u00een spitalele acute, c\u00e2t \u0219i \u00een ambulatoriu. Timp de \u00eenjum\u0103t\u0103\u021bire 1-2 ore (scurt; efectul diuretic dispare \u00een 6 ore); debut 30-60 minute (oral) sau 5 minute (IV); efect maxim 1-2 ore; durat\u0103 6-8 ore. Indica\u021bie principal\u0103: <strong>edem \u00een insuficien\u021b\u0103 cardiac\u0103, edem pulmonar, ascit\u0103, leziune renal\u0103 acut\u0103 oliguric\u0103, hipercalcemie, hipertensiune refractar\u0103 (NU este de prim\u0103 inten\u021bie pentru HTA)<\/strong>. Dozaj tipic: <strong>Furosemida NU este un antihipertensiv de prim\u0103 inten\u021bie.<\/strong> Ac\u021bioneaz\u0103 prea scurt (efect de 6 ore) pentru controlul tensiunii arteriale o dat\u0103 pe zi, iar natiureza puternic\u0103 provoc\u0103 oscila\u021bii ale tensiunii arteriale. Rezervat pentru HTA cu edem concomitant, BCR avansat (TFG &lt;30 unde tiazidele e\u0219ueaz\u0103) sau hipertensiune rezistent\u0103. Contraindica\u021bii cheie: vede\u021bi lista complet\u0103 mai jos. Monitoriza\u021bi electroli\u021bii, creatinina \u0219i glicemia. <strong>Nu combina\u021bi cu litiu<\/strong> (diureticele tiazidice\/de ans\u0103 pot precipita toxicitatea litiului). <strong>Utilizarea \u00een sarcin\u0103 este specific\u0103 cazului<\/strong> (consulta\u021bi nota despre sarcin\u0103). Pentru majoritatea pacien\u021bilor hipertensivi, diureticele func\u021bioneaz\u0103 cel mai bine ca <strong>al doilea sau al treilea agent<\/strong> \u2014 de obicei combinat cu un BRA, inhibitor ACE sau blocant al canalelor de calciu, mai degrab\u0103 dec\u00e2t utilizat singur.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Ce beneficii ofer\u0103 MedsBase:<\/strong> Produc\u0103tor certificat WHO-GMP \u00b7 Ambalaj discret \u00b7 Livrare la nivel mondial \u00b7 Peste 1.400 de recenzii verificate <a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">ale clien\u021bilor<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Fiecare comand\u0103 este acoperit\u0103 de politica noastr\u0103 de <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica noastr\u0103 de Reexpediere Garantat\u0103<\/strong><\/a> \u2014 dac\u0103 coletul dumneavoastr\u0103 nu sose\u0219te \u00een 20 de zile lucr\u0103toare, \u00eel relivr\u0103m.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Medicamentele noastre generice sunt procurate de la produc\u0103tori certifica\u021bi WHO-GMP \u0219i expediate la nivel mondial \u00een ambalaje discrete \u0219i simple \u2014 f\u0103r\u0103 denumirea medicamentului pe exteriorul coletului. Pl\u0103\u021bile cu cardul sunt procesate printr-un procesor reglementat (descrierile de pe extrasul de cont includ un procesor de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 \u201cMedsBase\u201d sau numele vreunui medicament). Accept\u0103m \u0219i criptomonede \u0219i transferuri bancare SEPA. Fiecare comand\u0103 este sus\u021binut\u0103 de Politica noastr\u0103 de Asigurare pentru Relivrare.<\/p>\n<h2 class=\"wp-block-heading\">Ce este Lasix?<\/h2>\n<p>Lasix este un comprimat oral de 40 mg de furosemid\u0103 de la Sanofi, furnizat \u00een cutii de 30-180 de comprimate. Furosemida (denumit\u0103 frusemid\u0103 \u00een nomenclatura din UK\/India) a fost introdus\u0103 de Hoechst \u00een 1964 ca <strong>Lasix<\/strong> \u2014 \u201cDurat\u0103 de \u0219ase ore\u201d, perioada eponim\u0103 a efectului s\u0103u diuretic. Primul diuretic de tip loop \u0219i \u00eenc\u0103 cel mai prescris, cu utilizare extins\u0103 at\u00e2t \u00een spitalele acute, c\u00e2t \u0219i \u00een ambulatoriu.<\/p>\n<h2 class=\"wp-block-heading\">Cum ac\u021bioneaz\u0103 furosemida<\/h2>\n<p>Furosemida inhib\u0103 <strong>NKCC2 (cotransportor Na-K-2Cl) \u00een ramura ascendent\u0103 groas\u0103 a ans\u0103i Henle<\/strong>. Efectele secundare:<\/p>\n<ul>\n<li><strong>Reducere dramatic\u0103 a reabsorb\u021biei de sodiu<\/strong> \u2014 diureticele de tip loop blocheaz\u0103 cel mai mare segment de reabsorb\u021bie a sodiului din nefron; p\u00e2n\u0103 la 25% din sodiul filtrat poate fi excretat<\/li>\n<li><strong>Diurez\u0103 intens\u0103<\/strong> \u00een 1-2 ore de la administrarea oral\u0103 (5 minute IV) \u2014 util\u0103 \u00een insuficien\u021ba cardiac\u0103 acut\u0103 decompensat\u0103 \u0219i edemul pulmonar<\/li>\n<li><strong>Pierdere de magneziu \u0219i calciu<\/strong> pe l\u00e2ng\u0103 sodiu \u0219i potasiu \u2014 \u00een contrast cu tiazidele care re\u021bin calciul<\/li>\n<li><strong>Vasodilata\u021bie venoas\u0103 direct\u0103<\/strong> \u00een c\u00e2teva minute de la administrarea IV \u2014 contribuie la ameliorarea simptomelor \u00een edemul pulmonar acut \u00eenainte de apari\u021bia diurezei<\/li>\n<li><strong>Activeaz\u0103 sinteza prostaglandinelor<\/strong> \u00een rinichi \u2014 fundamentul interac\u021biunii cu AINS (AINS atenueaz\u0103 efectul diureticelor de tip loop)<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Utiliz\u0103ri aprobate \u0219i bazate pe dovezi<\/h2>\n<ul>\n<li><strong>Edem \u00een insuficien\u021b\u0103 cardiac\u0103, edem pulmonar, ascit\u0103, leziune renal\u0103 acut\u0103 oliguric\u0103, hipercalcemie, hipertensiune refractar\u0103 (NU este de prim\u0103 inten\u021bie \u00een HTN)<\/strong> \u2014 indica\u021bie principal\u0103<\/li>\n<li><strong>Insuficien\u021b\u0103 cardiac\u0103 acut\u0103 decompensat\u0103 \/ edem pulmonar<\/strong> \u2014 bolus IV cu sau f\u0103r\u0103 nitrat<\/li>\n<li><strong>Insuficien\u021b\u0103 cardiac\u0103 cronic\u0103 cu edem sau congestie<\/strong><\/li>\n<li><strong>Ascit\u0103 cirotic\u0103<\/strong> (combinat cu spironolacton\u0103)<\/li>\n<li><strong>Leziune renal\u0103 acut\u0103 oliguric\u0103<\/strong> \u2014 pentru conversia leziunii renale acute oligurice \u00een poliuric\u0103 (NU \u00eembun\u0103t\u0103\u021be\u0219te supravie\u021buirea; faciliteaz\u0103 gestionarea lichidelor)<\/li>\n<li><strong>Hipercalcemie malign\u0103<\/strong> \u2014 dup\u0103 rehidratare adecvat\u0103 cu ser fiziologic<\/li>\n<li><strong>Hipertensiune rezistent\u0103<\/strong> cu edem concomitant sau boal\u0103 renal\u0103 cronic\u0103 avansat\u0103 (eGFR &lt;30)<\/li>\n<\/ul>\n<p><strong>Dovezile din studiile pivotale:<\/strong> <strong>Studiul DOSE (2011)<\/strong> \u2014 furosemid\u0103 \u00een doze mari vs doze mici, bolus vs perfuzie continu\u0103 \u00een insuficien\u021b\u0103 cardiac\u0103 acut\u0103; nicio diferen\u021b\u0103 de mortalitate, dozele mari au oferit ameliorare mai rapid\u0103 a simptomelor cu pre\u021bul unei cre\u0219teri mai mari a creatinei. <strong>TRANSFORM-HF (2023)<\/strong> \u2014 torasemid\u0103 vs furosemid\u0103 \u00een insuficien\u021b\u0103 cardiac\u0103 nu a ar\u0103tat nicio diferen\u021b\u0103 semnificativ\u0103 de mortalitate, sus\u021bin\u00e2nd furosemida ca fiind echivalent\u0103 \u00een practic\u0103. Baza de dovezi istorice este \u00een mare parte observa\u021bional\u0103, av\u00e2nd \u00een vedere c\u0103 diureticele de ans\u0103 preced standardele moderne de studiu.<\/p>\n<h2 class=\"wp-block-heading\">Doza de Lasix<\/h2>\n<p><strong>Doza pentru insuficien\u021b\u0103 cardiac\u0103:<\/strong> <strong>Furosemida NU este un antihipertensiv de prim\u0103 inten\u021bie.<\/strong> Ac\u021bioneaz\u0103 prea scurt (6 ore) pentru controlul zilnic al tensiunii arteriale, iar natriureza puternic\u0103 provoac\u0103 varia\u021bii ale tensiunii arteriale. Rezerva\u021bi pentru HTA cu edem concomitant, BCR avansat (TFG &lt;30 unde tiazidele e\u0219ueaz\u0103) sau hipertensiune rezistent\u0103.<\/p>\n<p><strong>Alte indica\u021bii:<\/strong> <strong>Insuficien\u021b\u0103 cardiac\u0103 cronic\u0103:<\/strong> 20-40 mg pe zi ini\u021bial; titra\u021bi la 40-500 mg\/zi sau \u00een doze \u00eemp\u0103r\u021bite de dou\u0103 ori pe zi, ghidat de greutatea zilnic\u0103 \u0219i simptome. <strong>Insuficien\u021b\u0103 cardiac\u0103 acut\u0103 decompensat\u0103 \/ edem pulmonar:<\/strong> 40-80 mg IV bolus (sau echivalentul dozei acas\u0103); repeta\u021bi dup\u0103 30-60 minute dac\u0103 nu apare diurez\u0103; ad\u0103uga\u021bi nitrat IV pentru reducerea post\u00eenc\u0103rc\u0103rii. <strong>Ascit\u0103 cirotic\u0103:<\/strong> furosemid\u0103 40 mg + spironolacton\u0103 100 mg (raport 1:2,5); titra\u021bi ambele. <strong>Hipercalcemie malign\u0103:<\/strong> dup\u0103 rehidratare IV adecvat\u0103 cu ser fiziologic, furosemid\u0103 20-40 mg IV la fiecare 6 ore pentru a promova diureza calciuric\u0103.<\/p>\n<p><strong>Administrare:<\/strong> o dat\u0103 pe zi (sau de dou\u0103 ori pe zi pentru doze mari de diuretice de ans\u0103 \u00een insuficien\u021b\u0103 cardiac\u0103), diminea\u021ba. Administrarea seara provoac\u0103 nicturie \u0219i ar trebui evitat\u0103 c\u00e2nd este posibil. Lua\u021bi la aceea\u0219i or\u0103 \u00een fiecare zi. Alimenta\u021bia nu afecteaz\u0103 semnificativ absorb\u021bia pentru niciunul dintre aceste diuretice.<\/p>\n<p><strong>Program de monitorizare:<\/strong><\/p>\n<ul>\n<li><strong>Valori ini\u021biale:<\/strong> uree, electroli\u021bi (\u00een special potasiu \u0219i sodiu), creatinin\u0103, eGFR, glucoz\u0103, acid uric seric. Tensiunea arterial\u0103 acas\u0103 sau \u00een clinic\u0103 \u0219i greutatea zilnic\u0103 pentru pacien\u021bii cu insuficien\u021b\u0103 cardiac\u0103.<\/li>\n<li><strong>la 1-2 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eenceperea sau modificarea dozei:<\/strong> repetarea electroli\u021bilor \u0219i a creatininei. A\u0219tepta\u021bi modific\u0103ri minore ale electroli\u021bilor; investiga\u021bi modific\u0103ri substan\u021biale.<\/li>\n<li><strong>4-6 s\u0103pt\u0103m\u00e2ni:<\/strong> evaluarea tensiunii arteriale \u0219i panelul metabolic complet.<\/li>\n<li><strong>Continuu:<\/strong> electroli\u021bi anuali, acid uric, glucoz\u0103 \u0219i panel lipidic odat\u0103 stabilizat. Mai frecvent \u00een insuficien\u021b\u0103 renal\u0103 cronic\u0103, insuficien\u021b\u0103 cardiac\u0103 sau la terapie combinat\u0103.<\/li>\n<li><strong>\u00centrerupe\u021bi sau reduce\u021bi doza la:<\/strong> sodiu &lt;130 cu simptome, potasiu 5,5, cre\u0219tere creatinin\u0103 &gt;30%, gut\u0103 nou\u0103, simptome severe de deshidratare.<\/li>\n<\/ul>\n<p><strong>\u00centrerupere:<\/strong> nu exist\u0103 sindrom de sevraj, dar \u00eentreruperea brusc\u0103 poate provoca reten\u021bie de volum de tip rebound la pacien\u021bii cu IC sub doze cronice mari de diuretice de ans\u0103 \u2014 reduce\u021bi progresiv doza acolo unde este posibil \u0219i monitoriza\u021bi greutatea.<\/p>\n<ul>\n<li><strong>Biodisponibilitate oral\u0103 foarte variabil\u0103 (10-90%).<\/strong> Torasemida are o biodisponibilitate de 80-100% \u0219i este preferat\u0103 la pacien\u021bii cu edem intestinal sau r\u0103spuns inconsecvent la furosemid\u0103 oral\u0103.<\/li>\n<li><strong>Ototoxicitate<\/strong> la doze IV mari \u0219i perfuzare rapid\u0103 \u2014 rar la administrare oral\u0103 sau IV moderat\u0103. Evita\u021bi dozele \u00een bolus rapid &gt;80 mg IV.<\/li>\n<li><strong>\u201cFenomenul de fr\u00e2nare\u201d<\/strong> \u2014 utilizarea cronic\u0103 a diureticelor de tip loop produce hipertrofie tubular\u0103 distal\u0103 care compenseaz\u0103. Ad\u0103uga\u021bi o tiazid\u0103 (metolazon 2,5-5 mg) sau HCTZ pentru \u201cblocaj secven\u021bial al nefronului\u201d \u00een edem refractar.<\/li>\n<li><strong>Biodisponibilitatea scade cu edemul peretelui intestinal<\/strong> (pacien\u021bi cu IC congestiv\u0103) \u2014 o cauz\u0103 frecvent\u0103 a aparentei \u201crezisten\u021be la furosemid\u0103\u201d care r\u0103spunde la dozajul IV.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Efecte Secundare<\/h2>\n<p><strong>Frecvente (&gt;1%):<\/strong><\/p>\n<ul>\n<li><strong>Hipokaliemie<\/strong> \u2014 mai sever dec\u00e2t la tiazide; monitoriza\u021bi \u00eendeaproape<\/li>\n<li><strong>Hipomagnezemie<\/strong> \u2014 specific loop; contribuie la riscul de aritmie<\/li>\n<li><strong>Hiponatremie<\/strong><\/li>\n<li><strong>Hipocalcemie<\/strong> (direc\u021bie opus\u0103 fa\u021b\u0103 de tiazide; exploatat terapeutic \u00een hipercalcemie)<\/li>\n<li><strong>Leziune renal\u0103 acut\u0103 pre-renal\u0103<\/strong> \u00een caz de diurez\u0103 excesiv\u0103, deshidratare sau utilizare concomitent\u0103 de AINS\/ACEi+ARB<\/li>\n<li><strong>Ototoxicitate<\/strong> la doze IV mari (&gt;160 mg \u00een bolus) sau perfuzare rapid\u0103<\/li>\n<li><strong>Hiperuricemie<\/strong> \u0219i gut\u0103<\/li>\n<li><strong>Hiperglicemie moderat\u0103<\/strong> (mai pu\u021bin dec\u00e2t cu tiazide)<\/li>\n<li><strong>Hipotenziune postural\u0103<\/strong><\/li>\n<li><strong>Erup\u021bie fotosensibil\u0103<\/strong><\/li>\n<\/ul>\n<p><strong>Pu\u021bin frecvente, dar clinic importante:<\/strong><\/p>\n<ul>\n<li><strong>Hiponatremie sever\u0103<\/strong> \u2014 \u00een special la persoanele \u00een v\u00e2rst\u0103 cu diete s\u0103race \u00een sare, st\u0103ri predispuse la SIADH sau \u00een combina\u021bie cu SSRI. Se poate manifesta prin confuzie, c\u0103deri sau convulsii.<\/li>\n<li><strong>Pancreatit\u0103<\/strong> \u2014 efect rar al clasei de tiazide\/loop; \u00eentrerupe\u021bi imediat la apari\u021bia durerii abdominale superioare cu cre\u0219tere a lipazei<\/li>\n<li><strong>Trombocitopenie, leucopenie, agranulocitoz\u0103<\/strong> \u2014 reac\u021bii rare de hipersensibilitate (mai frecvente la tiazide dec\u00e2t la diureticele de ans\u0103)<\/li>\n<li><strong>Miopie acut\u0103 \u0219i glaucom cu unghi \u00eenchis<\/strong> \u2014 reac\u021bie rar\u0103 din clasa sulfonamidelor, care apare \u00een c\u00e2teva ore sau zile de la \u00eenceperea tratamentului; \u00eentrerupe\u021bi imediat dac\u0103 apar dureri oculare sau modific\u0103ri ale vederii<\/li>\n<li><strong>Sindromul Stevens-Johnson \/ necroliz\u0103 epidermic\u0103 toxic\u0103<\/strong> \u2014 extrem de rar, dar raportat<\/li>\n<li><strong>Ototoxicitate<\/strong> la doze IV mari sau perfuzare rapid\u0103 \u2014 de obicei reversibil; pierderea permanent\u0103 a auzului rar\u0103<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Contraindica\u021bii<\/h2>\n<ul>\n<li>Anurie (f\u0103r\u0103 r\u0103spuns la diureticele de tip bucl\u0103 \u00een absen\u021ba perfuziei renale)<\/li>\n<li>Hipersensibilitate la sulfonamide<\/li>\n<li>Hipokaliemie sau hiponatremie sever\u0103 ini\u021bial\u0103 (&lt;3,0 sau &lt;125)<\/li>\n<li>Deshidratare sever\u0103 \u0219i azotemie prerenal\u0103<\/li>\n<li>Com\u0103 hepatic\u0103 (poate precipita prin modific\u0103ri electrolitice)<\/li>\n<\/ul>\n<p><strong>Sarcina:<\/strong> evitate pentru hipertensiunea arterial\u0103 obi\u0219nuit\u0103; utilizate doar pentru indica\u021bii clare (edem pulmonar, insuficien\u021b\u0103 cardiac\u0103 rezistent\u0103) sub \u00eendrumare specializat\u0103. Diureticele de tip bucl\u0103 trec placenta \u0219i pot reduce produc\u021bia de urin\u0103 fetal\u0103.<\/p>\n<p><strong>Al\u0103ptarea:<\/strong> \u00een general acceptabile la doze mici; dozele mari pot suprima lacta\u021bia (\u00een special tiazidele). Antihipertensive alternative (propranolol, nifedipin\u0103) sunt preferate atunci c\u00e2nd este posibil.<\/p>\n<h2 class=\"wp-block-heading\">Interac\u021biuni medicamentoase<\/h2>\n<ul>\n<li><strong>Litiu \u2014 INTERAC\u021aIUNE CRITIC\u0102.<\/strong> Diureticele tiazidice \u0219i cele de ans\u0103 reduc clearance-ul renal al litiului \u0219i pot precipita toxicitatea acestuia. Evita\u021bi combina\u021bia dac\u0103 este posibil; dac\u0103 este inevitabil, monitoriza\u021bi nivelurile de litiu s\u0103pt\u0103m\u00e2nal \u00een prima lun\u0103 \u0219i reduce\u021bi doza de litiu cu 25-50%.<\/li>\n<li><strong>AINS<\/strong> \u2014 reduc efectul diuretic (prin blocarea prostaglandinelor) \u0219i cresc substan\u021bial riscul de insuficien\u021b\u0103 renal\u0103 acut\u0103 atunci c\u00e2nd sunt combinate cu ACEi\/ARB (\u201ctripla lovitur\u0103\u201d). Utiliza\u021bi paracetamol preferen\u021bial pentru durerea cronic\u0103.<\/li>\n<li><strong>Inhibitori ACE \u0219i ARB<\/strong> \u2014 combina\u021bia este standard \u0219i benefic\u0103 \u00een HTA; ad\u0103ugarea de ACEi\/ARB blocheaz\u0103 activarea compensatorie a sistemului RAAS \u0219i poten\u021beaz\u0103 efectul diuretic. Monitoriza\u021bi potasiul \u0219i creatinina.<\/li>\n<li><strong>Suplimente de potasiu \u0219i diuretice economisitoare de potasiu<\/strong> \u2014 adesea necesare pentru a compensa hipokaliemia indus\u0103 de diureticele de tip loop\/tiazidic. Monitoriza\u021bi potasiul; evita\u021bi corec\u021bia excesiv\u0103.<\/li>\n<li><strong>Digoxin\u0103<\/strong> \u2014 hipokaliemia poten\u021beaz\u0103 toxicitatea digoxinului (diureticele loop \u0219i tiazidice); spironolactona reduce direct clearance-ul digoxinului. Monitoriza\u021bi nivelurile de digoxin \u0219i potasiu la \u00eenceperea sau modificarea diureticului.<\/li>\n<li><strong>Corticoesteroide orale, amfotericina B, laxative stimulante<\/strong> \u2014 hipokaliemie aditiv\u0103 (diuretice loop\/tiazidice) sau necesitate mascat\u0103 de potasiu (spironolacton\u0103).<\/li>\n<li><strong>Antidiabetice orale, insulin\u0103<\/strong> \u2014 diureticele tiazidice \u0219i (\u00een mai mic\u0103 m\u0103sur\u0103) cele loop \u00eenr\u0103ut\u0103\u021besc toleran\u021ba la glucoz\u0103; poate fi necesar\u0103 ajustarea dozei.<\/li>\n<li><strong>Colestiramin\u0103 \/ colestipol<\/strong> \u2014 reduce absorb\u021bia tiazidelor \u0219i a diureticelor de ans\u0103 cu 40-85%. Administrarea trebuie separat\u0103 cu 4 ore.<\/li>\n<li><strong>Antibiotice aminoglicozidice (gentamicin\u0103, amikacin\u0103)<\/strong> \u2014 ototoxicitate aditiv\u0103. Evita\u021bi utilizarea concomitent\u0103 la doze IV mari.<\/li>\n<li><strong>Alcool<\/strong> \u2014 hipotensiune postural\u0103 aditiv\u0103.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Pozi\u021bia Lasix \u00een Clasa Diureticelor<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Clas\u0103<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Reprezentan\u021bi<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Utilizare tipic\u0103<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tiazid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">HCTZ<\/a>, clortalidon\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HTN prim-line, pietre de calciu, DI nefrogen<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Asem\u0103n\u0103tor tiazidelor<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/natrilix-sr\/\">Indapamid\u0103<\/a>, metolazon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HTN (v\u00e2rstnici, dovezi HYVET), blocaj secven\u021bial al nefronului<\/td>\n<\/tr>\n<tr style=\"background:#fff3cd;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Diuretic de ans\u0103 (scurt)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/lasix\/\">Furosemid\u0103<\/a>, bumetanid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Edem pulmonar acut, ICC, ascit\u0103, hipercalcemie<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Bucl\u0103 (lung\u0103)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/dytor\/\">Torasemid\u0103<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">IC cronic\u0103, HTA (singura bucl\u0103 cu dovezi pentru HTA), edem la BCR<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Antagonist de aldosteron\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/ro\/aldactone\/\">Spironolacton\u0103<\/a>, eplerenon\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">IC-FER (RALES), HTA rezistent\u0103 (PATHWAY-2), sindrom Conn, ascit\u0103 cirotic\u0103<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Alte economizoare de potasiu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Amilorid\u0103, triamteren (de obicei \u00een combina\u021bii)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prevenirea hipokaliemiei atunci c\u00e2nd se adaug\u0103 la bucl\u0103\/tiazidic\u0103<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Anhidraz\u0103 carbonic\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Acetazolamid\u0103<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Mal de altitudine, glaucom, alcaloz\u0103 metabolic\u0103<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Depozitare<\/h2>\n<p>P\u0103stra\u021bi Lasix la o temperatur\u0103 sub 25\u00b0C \u00een ambalajul original blister. Depozita\u021bi \u00eentr-un loc inaccesibil copiilor.<\/p>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3 class=\"wp-block-heading\">C\u00e2nd ar trebui s\u0103 iau Lasix \u2014 diminea\u021ba sau seara?<\/h3>\n<p><strong>Diminea\u021ba<\/strong> \u00een aproape toate cazurile. Efectul diuretic produce o cre\u0219tere a produc\u021biei de urin\u0103 timp de 2-4 ore dup\u0103 administrare. Administrarea seara provoac\u0103 nocturie \u0219i perturb\u0103 somnul. Pacien\u021bii care iau diuretice de ans\u0103 de dou\u0103 ori pe zi le administreaz\u0103 de obicei la micul dejun \u0219i la pr\u00e2nz (nu la culcare).<\/p>\n<h3 class=\"wp-block-heading\">Este Lasix un medicament de prim\u0103 linie pentru tensiunea arterial\u0103?<\/h3>\n<p><strong>Nu.<\/strong> Diureticele de ans\u0103 sunt <strong>nu sunt antihipertensive de prim\u0103 linie<\/strong> \u2014 ac\u021bioneaz\u0103 prea scurt \u0219i produc varia\u021bii ale tensiunii arteriale. Diureticele de ans\u0103 sunt utilizate pentru hipertensiune doar \u00een situa\u021bii specifice: edem \u00een insuficien\u021b\u0103 cardiac\u0103 concomitent\u0103, boal\u0103 renal\u0103 cronic\u0103 avansat\u0103 (eGFR &lt;30) c\u00e2nd tiazidele e\u0219ueaz\u0103 sau hipertensiune rezistent\u0103 ca tratament adjunct. Pentru hipertensiunea standard, alege\u021bi o tiazid\u0103, un ARB, un inhibitor ACE sau un blocant al canalelor de calciu.<\/p>\n<h3 class=\"wp-block-heading\">Va afecta Lasix nivelul meu de potasiu?<\/h3>\n<p>Da \u2014 Lasix <strong>scade<\/strong> potasiul prin cre\u0219terea excre\u021biei de potasiu la nivelul tubului distal. Monitoriza\u021bi la ini\u021biere, dup\u0103 1-2 s\u0103pt\u0103m\u00e2ni \u0219i periodic. Riscul de hipokaliemie este <strong>minimizat prin combinarea<\/strong> Lasix cu un ARB sau inhibitor ACE \u2014 care este combina\u021bia standard \u00een hipertensiune oricum. Dac\u0103 potasiul scade sub 3,5 \u00een utilizarea izolat\u0103 a diureticului, ad\u0103uga\u021bi suplimente de potasiu, o diet\u0103 bogat\u0103 \u00een potasiu sau o doz\u0103 mic\u0103 de un agent care economise\u0219te potasiu (spironolacton\u0103, eplerenon\u0103 sau un <a href=\"https:\/\/medsbase.com\/ro\/amifru\/\">amilorid\u0103<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Am gut\u0103 \u2014 pot lua Lasix?<\/h3>\n<p>Cu precau\u021bie. Diureticele tiazidice \u0219i (\u00een mai mic\u0103 m\u0103sur\u0103) cele de tip bucl\u0103 cresc acidul uric seric prin competi\u021bia pentru excre\u021bia la nivelul tubului proximal. La pacien\u021bii predispu\u0219i la gut\u0103: prefera\u021bi combina\u021biile pe baz\u0103 de losartan (<a href=\"https:\/\/medsbase.com\/ro\/cosart-h\/\">Cosart H<\/a>, <a href=\"https:\/\/medsbase.com\/ro\/cozartan-h\/\">Cozartan H<\/a>) al c\u0103rui component losartan este unic uricosuric \u0219i contrabalanseaz\u0103 cre\u0219terea de urat provocat\u0103 de tiazid\u0103. Dac\u0103 Lasix este deja utilizat \u0219i apar accese de gut\u0103, ad\u0103uga\u021bi sau continua\u021bi terapia de reducere a uratelor (alopurinol) \u00een loc s\u0103 \u00eentrerupe\u021bi Lasix complet.<\/p>\n<h3 class=\"wp-block-heading\">Sunt diabetic \u2014 este Lasix sigur?<\/h3>\n<p>\u00cen mare parte da, dar fi\u021bi con\u0219tient c\u0103 tiazidele \u0219i (\u00eentr-o m\u0103sur\u0103 mai mic\u0103) diureticele de ans\u0103 <strong>\u00eenr\u0103ut\u0103\u021besc modest toleran\u021ba la glucoz\u0103<\/strong> (cre\u0219tere medie a glicemiei \u00een post 5-8 mg\/dL, HbA1c 0,1-0,3%). Beneficiul asupra tensiunii arteriale dep\u0103\u0219e\u0219te acest efect la majoritatea diabeticilor. Dac\u0103 dori\u021bi o combina\u021bie metabolic mai neutr\u0103, ARB+CCB este o alternativ\u0103 (<a href=\"https:\/\/medsbase.com\/ro\/olmezest-am\/\">Olmezest AM<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Pot lua ibuprofen cu Lasix?<\/h3>\n<p>Utilizarea ocazional\u0103 pe termen scurt este de obicei \u00een regul\u0103. NSAID-urile utilizate zilnic pe termen lung (ibuprofen, diclofenac, naproxen) <strong>reduc efectul diuretic \u0219i antihipertensiv<\/strong> a Lasix (blocarea prostaglandinelor) \u0219i cresc substan\u021bial riscul de AKI atunci c\u00e2nd sunt combinate cu un inhibitor ACE sau ARB \u2014 \u201ctriplul impact\u201d. Utiliza\u021bi paracetamol \u00een mod preferen\u021bial pentru durerea cronic\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Voi urina mai mult noaptea?<\/h3>\n<p>De obicei nu, dac\u0103 lua\u021bi Lasix diminea\u021ba. Efectul diuretic atinge maximul la 2-4 ore dup\u0103 administrare \u0219i se diminueaz\u0103 \u00een mare parte p\u00e2n\u0103 seara. Nocturia este o pl\u00e2ngere frecvent\u0103 c\u00e2nd pacien\u021bii trec la administrarea seara; reveni\u021bi la administrarea diminea\u021ba \u0219i nocturia se rezolv\u0103 \u00een 1-3 zile.<\/p>\n<h3 class=\"wp-block-heading\">Pot lua Lasix \u00een timpul sarcinii?<\/h3>\n<p>Evitat \u00een mod obi\u0219nuit. Diureticele de ans\u0103 trec prin placent\u0103 \u0219i pot afecta f\u0103tul. Pentru hipertensiunea \u00een sarcin\u0103, trece\u021bi la <a href=\"https:\/\/medsbase.com\/ro\/labebet\/\">labetalol<\/a>, metildopa sau nifedipin\u0103. Diureticele sunt utilizate \u00een sarcin\u0103 doar pentru indica\u021bii specifice (edem pulmonar, insuficien\u021b\u0103 cardiac\u0103 rezistent\u0103) sub supraveghere specializat\u0103.<\/p>\n<h3 class=\"wp-block-heading\">Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi-l c\u00e2t mai cur\u00e2nd v\u0103 aminti\u021bi, cu excep\u021bia cazului \u00een care este aproape timpul pentru urm\u0103toarea doz\u0103 \u2014 \u00een acest caz omite\u021bi doza ratat\u0103. Nu dubla\u021bi doza. O singur\u0103 doz\u0103 ratat\u0103 nu afecteaz\u0103 semnificativ controlul tensiunii arteriale pe termen lung sau al fluidelor.<\/p>\n<h3 class=\"wp-block-heading\">Unde pot cump\u0103ra Lasix online?<\/h3>\n<p>Pute\u021bi cump\u0103ra Lasix (40 mg furosemid\u0103, 30-180 comprimate) de la MedsBase cu ambalaj discret \u0219i livrare la nivel mondial.<\/p>\n<h2 class=\"wp-block-heading\">Antihipertensive \u0219i Diuretice Asem\u0103n\u0103toare pe MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amifru\/\">Amifru \u2014 Furosemid\u0103 + Amilorid\u0103 (diuretic de ans\u0103 + economisitor de potasiu)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/amlode\/\">Amlode \u2014 Amlodipin\u0103 5\/10 mg (CCB)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/aquazide\/\">Aquazide \u2014 Hidroclorotiazid\u0103 (HCTZ) tiazidic\u0103<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/dytor\/\">Dytor \u2014 Torasemid\u0103 (diuretic de ans\u0103, biodisponibilitate mai predictibil\u0103)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/losar\/\">Losar \u2014 Losartan (ARB asociat cu diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/telmaheal\/\">Telmaheal \u2014 Telmisartan (partener ARB pentru diuretic)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/high-blood-pressure-medication\/\"><strong>R\u0103sfoi\u021bi toate medicamentele pentru hipertensiune arterial\u0103<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 Dezaprobare medical\u0103.<\/strong> Aceast\u0103 pagin\u0103 are scop informativ \u0219i nu \u00eenlocuie\u0219te sfatul medical al unui medic calificat. Hipertensiunea, insuficien\u021ba cardiac\u0103 \u0219i aritmiile necesit\u0103 diagnostic, monitorizare \u0219i individualizarea dozei de c\u0103tre un medic \u2014 utiliza\u021bi \u00eentotdeauna beta-blocante sub \u00eendrumare medical\u0103.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Alternative conexe<\/h3>\n<p>Alte produse din <strong>Afec\u021biuni cronice<\/strong> pe care clien\u021bii le vizualizeaz\u0103 de asemenea:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/atorvatin\/\">Atorvatin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/asthalin-respules\/\">Asthalin Respules<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/tamilong\/\">Tamilong<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/glimith\/\">Glimith<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/nebicard\/\">Nebicard<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Lasix este comprimatele de furosemid\u0103 40 mg ale Sanofi \u2014 diureticul de referin\u021b\u0103 din clasa loop din 1964. Blocheaz\u0103 NKCC2 \u00een ramura ascendent\u0103 groas\u0103; produce natriurez\u0103 dramatic\u0103 (p\u00e2n\u0103 la 25% din sodiul filtrat) cu debut \u00een 30-60 minute la administrare oral\u0103. Utilizat \u00een edem pulmonar acut, insuficien\u021b\u0103 cardiac\u0103 cronic\u0103, ascit\u0103 cirotic\u0103, leziune renal\u0103 acut\u0103 oliguric\u0103, hipercalcemie \u0219i hipertensiune refractar\u0103. Nu este de prim\u0103 inten\u021bie pentru hipertensiunea standard. Biodisponibilitatea oral\u0103 variaz\u0103 \u00eentre 10-90%.<\/p>","protected":false},"featured_media":57142,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[4239,4241,4242],"class_list":{"0":"post-57141","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-frusemide","11":"product_tag-furosemide","12":"product_tag-lasix","14":"first","15":"instock","16":"shipping-taxable","17":"purchasable","18":"product-type-variable","19":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/57141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=57141"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/57142"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=57141"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=57141"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=57141"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=57141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}